A PHASE-II STUDY OF IDARUBICIN (4-DEMETHOXYDAUNORUBICIN) IN ADVANCED MYELOMA

被引：25

作者：

CHISESI, T ^{[1
]}

CAPNIST, G ^{[1
]}

DEDOMINICIS, E ^{[1
]}

DINI, E ^{[1
]}

机构：

[1] SAN BORTOLO HOSP,DEPT CARDIOL,I-36100 VICENZA,ITALY

来源：

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1988年 / 24卷 / 04期

关键词：

D O I：

10.1016/0277-5379(88)90299-4

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：681 / 684

页数：4

共 15 条

[1] ALEXANIAN R, 1984, CANCER, V53, P583, DOI 10.1002/1097-0142(19840201)53:3<583::AID-CNCR2820530336>3.0.CO
[2] 2-1
[3] CARELLA AM, 1985, CANCER, V55, P1452, DOI 10.1002/1097-0142(19850401)55:7<1452::AID-CNCR2820550705>3.0.CO
[4] 2-D
[5] ANTI-LEUKEMIC ACTIVITY OF 4-DEMETHOXYDAUNORUBICIN IN MICE
CASAZZA, AM
PRATESI, G
GIULIANI, F
DIMARCO, A
[J]. TUMORI, 1980, 66 (05) : 549 - 564
[6] CHISESI T, 1983, PRELIMINARY RESULTS, P103
[7] DAGHESTANI AN, 1985, CANCER RES, V45, P1408
[8] Di Marco A, 1978, Antibiot Chemother (1971), V23, P12
[9] DURIE BGM, 1975, CANCER, V36, P842, DOI 10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO
[10] 2-U